Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Randomized Controlled Trial of Efficacy and Safety of Intravenous Ketamine for Chronic Daily Headaches: The KetHead Study

NCT05306899 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05306899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05306899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Randomized Controlled Trial of Efficacy and Safety of Intravenous Ketamine for Chronic Daily Headaches: The KetHead Study
Lead sponsor
University Health Network, Toronto
Phase
Phase 3
Overall status
Recruiting
Start date
June 1, 2022
Completion date
June 1, 2027
Enrollment
56 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic daily headache